What Does Insilico Medicine Do?

Total employees287
HeadquartersShatin
Founded2014

Insilico Medicine is a clinical-stage artificial intelligence (AI)-driven drug discovery and development company. Leveraging its proprietary Pharma.AI platform, which spans biology, chemistry, and clinical development analysis, Insilico aims to accelerate the creation of innovative medicines for unmet medical needs. The company focuses on discovering and developing novel therapeutics for cancer, fibrosis, immunology, central nervous system (CNS) diseases, and aging-related diseases. Insilico Medicine has a pipeline of internally discovered therapeutic programs, with several candidates advancing to clinical trials. Their mission is to accelerate drug discovery and development through advanced AI and make novel treatments more rapidly available to patients.

Where Is Insilico Medicine's Headquarters?

HQ Function

Serves as the global headquarters, overseeing strategic direction, core AI research and development, and international operations for drug discovery programs.

Notable Features:

Located within the Hong Kong Science Park, a premier hub for innovation and technology, offering state-of-the-art facilities and fostering collaboration within a vibrant R&D ecosystem.

Work Culture:

A dynamic, fast-paced, and highly collaborative environment driven by scientific excellence and innovation. The culture encourages interdisciplinary teamwork among AI specialists, biologists, chemists, and clinical researchers with a shared mission to revolutionize drug discovery.

HQ Significance:

Strategically positioned in Asia's burgeoning biotech landscape, providing access to a rich talent pool, investment opportunities, and collaborative partnerships. Hong Kong's robust infrastructure and government support for R&D enhance its role as a global innovation center.

Values Reflected in HQ: The headquarters' location and setup reflect Insilico Medicine's core values of innovation, scientific rigor, global collaboration, and the pursuit of transformative healthcare solutions.

Location:

Insilico Medicine operates globally with a network of offices and research centers across North America (USA, Canada), Asia (Hong Kong, Shanghai, Seoul), and the Middle East (UAE). This international footprint supports diverse functions including AI-driven R&D, preclinical and clinical drug development, business development, strategic partnerships, and talent acquisition worldwide.

Street Address:

Units 518-528, 5/F, Bio-Informatics Centre, No. 2 Science Park West Avenue

City:

Shatin

State/Province:

New Territories

Country:

Hong Kong

Where Else Does Insilico Medicine Operate Around the World?

New York, NY, USA

Address: 99 Hudson Street, 5th Floor, New York, NY 10013

Expanding presence in the major US pharmaceutical market, engaging with regulatory bodies like the FDA, and fostering partnerships with US-based research institutions and companies.

Shanghai, China

Address: Room 1002, Building 1, Lane 555, Chuanqiao Road, Pudong New Area, Shanghai

Driving drug discovery and development efforts for the Asian market, particularly China, and collaborating with local academic and industry partners.

Abu Dhabi, UAE

Address: Office 209, 2nd Floor, Building A3, Al Maqam Tower, ADGM Square, Al Maryah Island, Abu Dhabi

Expanding research capabilities and exploring strategic partnerships and collaborations in the Middle East and North Africa (MENA) region, leveraging regional investments in technology and healthcare.

Montreal, QC, Canada

Address: 6666 Rue Saint-Urbain #300, Montreal, Quebec H2S 3H1

Strengthening R&D footprint in North America, focusing on AI innovation and collaboration with Canadian research institutions and AI talent.

Seoul, Republic of Korea

Address: #428, 4F, Bio-shared office space, 21, Baekbeom-ro 31-gil, Mapo-gu, Seoul

Expanding presence and partnerships in the dynamic South Korean biotech market, facilitating regional collaborations and clinical research activities.

Buying Intent Signals for Insilico Medicine

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Insilico Medicine? Meet the Executive Team

As of April 2025, Insilico Medicine' leadership includes:

Alex Zhavoronkov, PhD - Founder and Chief Executive Officer
Feng Ren, PhD - Co-CEO and Chief Scientific Officer
Alex Aliper, PhD - President
Michelle Chen, PhD, MBA - Chief Business Officer
Keith Mikule, CPA - Chief Financial Officer
Nirav Jhaveri, MD - Chief Medical Officer
Su Capello, PhD (Su-Eun Lee) - Chief Strategy Officer

Who's Investing in Insilico Medicine?

Insilico Medicine has been backed by several prominent investors over the years, including:

Warburg Pincus
Qiming Venture Partners
Pavilion Capital
Eight Roads Ventures
Prosperity7 Ventures (Aramco Ventures)
Deerfield Management
OrbiMed
Mirae Asset Capital
Lilly Asia Ventures
Sinovation Ventures
B Capital Group
Baidu Ventures

What Leadership Changes Has Insilico Medicine Seen Recently?

Hire3
Exits0

Insilico Medicine has made several key appointments to its executive team over the past 12 months, significantly strengthening its leadership in finance, clinical development, and strategy to support its ongoing growth and the advancement of its AI-driven drug discovery pipeline. No major executive departures have been publicly announced during this period.

New Appointments:

Keith Mikule, CPA, Keith Mikule was appointed as Chief Financial Officer, bringing extensive experience in financial leadership within the biotech and pharmaceutical industries to steer Insilico's financial strategy.
Nirav Jhaveri, MD, Nirav Jhaveri, MD, joined Insilico Medicine as Chief Medical Officer to lead the company's clinical development strategy and oversee its expanding pipeline of therapeutic candidates.
Su Capello, PhD (Su-Eun Lee), Dr. Su Capello was appointed as Chief Strategy Officer to drive strategic initiatives, corporate development, and long-term growth planning for the company.

What Technology (Tech Stack) Is Used byInsilico Medicine?

Discover the tools Insilico Medicine uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Insilico Medicine Email Formats and Examples

Insilico Medicine commonly uses standard corporate email formats, primarily [firstname].[lastname]@insilico.com. Variations like [firstinitial][lastname]@insilico.com may also be in use. For example, a person named Jane Doe might have an email address like jane.doe@insilico.com.

[firstname].[lastname]@insilico.com or [f][lastname]@insilico.com

Format

jane.doe@insilico.com

Example

75%

Success rate

What's the Latest News About Insilico Medicine?

Business WireMay 16, 2024

Insilico Medicine Enters into Cooperative Research and Development Agreement with the National Cancer Institute to Develop Novel Cancer Therapies

Insilico Medicine announced it has entered into a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI), part of the National Institutes of Health, to co-develop novel therapeutics for various types of cancer using Insilico's AI platform and NCI's expertise....more

GlobeNewswireApril 23, 2024

Insilico Medicine Presents Positive Topline Data from Phase I Clinical Trial of AI-Discovered TNF-α Inhibitor for Rheumatoid Arthritis at World-Leading Congress

Insilico Medicine presented positive topline data from its Phase I clinical trial of ISM3091, an AI-discovered and AI-developed TNFa inhibitor for rheumatoid arthritis. The study demonstrated good safety, tolerability, and favorable pharmacokinetics....more

Business WireApril 2, 2024

Insilico Medicine Appoints Keith Mikule, CPA, as Chief Financial Officer

Insilico Medicine announced the appointment of Keith Mikule, CPA, as its new Chief Financial Officer. Mr. Mikule brings over 20 years of financial leadership experience in the biotechnology and pharmaceutical industries....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Insilico Medicine, are just a search away.